Uhrf1 antibody (mAb) (Clone 1RC-1C10)
Host / Isotype
Mouse / IgG1, k
Reactivity
Human
Applications
ICC, IF, IHC, IP, WB
CloneNo.
1RC-1C10
Cat No : 61341 61341
Synonyms
Validation Data Gallery
Product Information
Tested Applications |
ICC, IF, IHC, IP, WB
Applications Validated by Active Motif: ICC/IF: 0.5 ug/ml dilution WB*: 1:1000 - 1:2,500 dilution *Note: Many chromatin-bound proteins are not soluble in a low salt nuclear extract and fractionate to the pellet. Therefore, we recommend a High Salt / Sonication Protocol when preparing nuclear extracts for Western blot. In addition, we recommend the addition of 0.05% Tween 20 to all blocking solutions to reduce background. |
Tested Reactivity | Human |
Host / Isotype | Mouse / IgG1, k |
Class | Monoclonal |
Type | Antibody |
Immunogen | This antibody was raised against a synthetic peptide corresponding to amino acid residue(s) 263-793 of human Uhrf1. |
Full Name | Uhrf1 antibody (mAb) (Clone 1RC-1C10) |
Synonyms | Uhrf1, Uhrf 1, ICBP90, RNF106, NP95, transcription factor, ubiquitin-like, polyclonal, antibody, antibodies |
Molecular weight | 96 kDa |
GenBank accession number | NP_001041666 |
Purification Method | Protein G Chromatography |
Buffer | Purified IgG in 70 mM Tris (pH 8), 105 mM NaCl, 32 mM glycine, 0.07 mM EDTA, 30% glycerol, and 0.035% sodium azide. Sodium azide is highly toxic. |
Storage | Some products may be shipped at room temperature. This will not affect their stability or performance. Avoid repeated freeze/thaw cycles by aliquoting items into single-use fractions for storage at -20°C for up to 2 years. Keep all reagents on ice when not in storage. |
Background Information
Uhrf1 (ubiquitin-like, containing PHD and RING finger domains 1) is a transcription and cell cycle regulator. It functions as a putative E3 ubiquitin-protein ligase. Uhrf1 is important for G1/S transition of the cell cycle. It is also believed that Uhrf1 may help recruit the DNA methyltransferase, DNMT1, to hemimethylated DNA and assist in the stabilization of DNMT1 with chromatin.